<h3>Gainers</h3>
<ul>
<li>Liminatus Pharma (NASDAQ:LIMN) stock increased by 24.3% to $1.33 during Wednesday's pre-market session. The company's market cap stands at $28.9 million. </li>
<li>Oncolytics Biotech (NASDAQ:ONCY) shares rose 16.76% to $1.02. The company's market cap stands at $94.4 million. </li>
<li>Ensysce Biosciences (NASDAQ:ENSC) stock rose 14.81% to $0.7. The company's market cap stands at $2.1 million. </li>
<li>PDS Biotechnology (NASDAQ:PDSB) shares rose 10.41% to $0.84. The market value of their outstanding shares is at $41.8 million. </li>
<li>Valneva (NASDAQ:VALN) stock increased by 10.36% to $10.01. The market value of their outstanding shares is at $786.4 million. </li>
<li>Lunai Bioworks (NASDAQ:LNAI) stock increased by 10.01% to $0.78. The market value of their outstanding shares is at $16.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Concord Medical Services (NYSE:CCM) shares declined by 10.3% to $3.5 during Wednesday's pre-market session. The market value of their outstanding shares is at $169.3 million. </li>
<li>Boston Scientific (NYSE:BSX) shares fell 9.27% to $83.13. The market value of their outstanding shares is at $135.8 billion. As per the press release, Q4 earnings came out today. </li>
<li>CDT Equity (NASDAQ:CDT) stock declined by 9.03% to $1.21. The company's market cap stands at $3.0 million. </li>
<li>VSee Health (NASDAQ:VSEE) shares declined by 7.43% to $0.32. The company's market cap stands at $11.3 million. </li>
<li>Cencora (NYSE:COR) stock decreased by 6.84% to $337.01. The market value of their outstanding shares is at $70.3 billion. The company's, Q1 earnings came out today. </li>
<li>NewGenIvf Group (NASDAQ:NIVF) shares fell 6.26% to $1.2. The company's market cap stands at $1.2 million. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ONCY

In Wednesday's pre-market session, Liminatus Pharma (LIMN) saw a significant gain of 24.3%, reaching $1.33, while Oncolytics Biotech (ONCY) rose 16.76% to $1.02. Other gainers included Ensysce Biosciences (ENSC) up 14.81% and PDS Biotechnology (PDSB) up 10.41%. Conversely, Concord Medical Services (CCM) fell 10.3% to $3.5, and Boston Scientific (BSX) dropped 9.27% to $83.13. Notable declines also included CDT Equity (CDT) and VSee Health (VSEE).

benzinga_article

iShares US Pharma

Oncolytics Biotech

iShares Global Healthcare

ALPS Medical Breakthrough

iShares Biotechnology ETF

Health Care Select Sector SPDR

VanEck Biotech ETF

Ensysce Biosciences

SPDR S&P Health

PDS Biotechnology

SPDR S&P Health Equip

First Trust NYSE Arca Biotech Index Fd

VSee Health

Liminatus Pharma

Ark Genomic Revolution ETF

VSEE HEALTH INC C/WTS (TO PUR COM)

Invesco Biotechnology & Genome ETF

SPDR S&P Biotech

iShares US Healthcare Providers

VG Health

Invesco Nasdaq Biotechnology ETF

12 Health Care Stocks Moving In Wednesday's Pre-Market Session